ERBB2 and breast carcinoma: A high Oncotype DX Recurrence Score is associated with pCR after neoadjuvant chemotherapy based on results of a retrospective analysis of the National Cancer Database of T1-T3 mostly N0 cohort of ER-positive, HER2-negative breast cancer patients [27].